PAR:ALBPS

Biophytis S.A. · PAR · Healthcare · EUR · FY for 2024

Figures on this page computed 2026-11-08 12:42 UTC

Last close

n/aEUR

Market data

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed
    • Computed from the filing for 2024
  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2024
    • Computed from the filing for 2024
    • Computed from the filing for 2024
    • Computed from the filing for 2024
    • Computed from the filing for 2024
    • Computed from the filing for 2024
  • n/aNet margin

    We do not hold this figure for this company, so there is nothing to place.

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2024
    • Computed from the filing for 2024
  • n/aFCF margin

    We do not hold this figure for this company, so there is nothing to place.

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2024
    • Computed from the filing for 2024
  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • Computed from the filing for 2024
    • Computed from the filing for 2024
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    EUR
    • computed

Five bars, one line

lens 7 of 9
n/a
0.63x
0.71x
1.15x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2024
Computed2024
Computed2024
Computed2024
Market datan/a

Each against its own average

3 of 5 read

Except where said otherwise: Computed from the filing for 2024

  • Salesn/a

    Its own average over 0 years.

  • Profit0.63x

    Its own average over 10 years, -16.6M.

  • Free cash flow0.71x

    Its own average over 10 years, -12.2M.

  • Debt1.15x

    Its own average over 10 years, 8.6M.

  • Pricen/a

    Its own average over 0 years. Market data

Profit is furthest from its own average, at 0.63 times.

Profit is 0.63 times its own 10-year average; Free cash flow is 0.71 times its own 10-year average; Debt is 1.15 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2024

  • Sales against its own 0-year averagen/a

    Not held.

    Source
    computed
    Statement
    income
    Fiscal year
    2024
    Reported in
    EUR
  • Profit against its own 10-year average0.63
    Source
    computed
    Statement
    income
    Fiscal year
    2024
    Reported in
    EUR
  • Free cash flow against its own 10-year average0.71
    Source
    computed
    Statement
    income
    Fiscal year
    2024
    Reported in
    EUR
  • Debt against its own 10-year average1.15
    Source
    computed
    Statement
    income
    Fiscal year
    2024
    Reported in
    EUR
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    EUR

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.